Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
3billion | RCV001808916 | SCV002059172 | likely benign | Koolen-de Vries syndrome | 2024-07-30 | criteria provided, single submitter | clinical testing | The variant was observed in gnomAD v4.1.0(allele count: 5, allele frequency 0.0003%), and in individuals without associated symptoms to Koolen-De Vries syndrome(3billion dataset). Therefore, this variant is classified as likely benign according to the recommendation of ACMG/AMP guideline. |
Labcorp Genetics |
RCV001808916 | SCV003476342 | likely pathogenic | Koolen-de Vries syndrome | 2024-10-22 | criteria provided, single submitter | clinical testing | This sequence change affects an acceptor splice site in intron 10 of the KANSL1 gene. It is expected to disrupt RNA splicing. Variants that disrupt the donor or acceptor splice site typically lead to a loss of protein function (PMID: 16199547), and loss-of-function variants in KANSL1 are known to be pathogenic (PMID: 22544363, 22544367). This variant is not present in population databases (gnomAD no frequency). Disruption of this splice site has been observed in individual(s) with KANSL1-related conditions (internal data). ClinVar contains an entry for this variant (Variation ID: 1333700). Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site. In summary, the currently available evidence indicates that the variant is pathogenic, but additional data are needed to prove that conclusively. Therefore, this variant has been classified as Likely Pathogenic. |